home.social

#clinicaltrials — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #clinicaltrials, aggregated by home.social.

  1. Creatv Bio Opens CLIA-Certified Laboratory to Support Oncology Drug Development

    MONMOUTH JUNCTION, N.J., May 13, 2026 /PRNewswire/ — Creatv Bio, a Division of Creatv MicroTech, Inc. (“Creatv”), a…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #biotechnology #ClinicalTrials&MedicalDiscoveries #CreatvMicroTech #Health #HealthCare&Hospitals #Inc. #medicalequipment #MedicalPharmaceuticals #Pharmaceuticals
    newsbeep.com/us/641021/

  2. Creatv Bio Opens CLIA-Certified Laboratory to Support Oncology Drug Development

    MONMOUTH JUNCTION, N.J., May 13, 2026 /PRNewswire/ — Creatv Bio, a Division of Creatv MicroTech, Inc. (“Creatv”), a…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #biotechnology #ClinicalTrials&MedicalDiscoveries #CreatvMicroTech #Health #HealthCare&Hospitals #Inc. #medicalequipment #MedicalPharmaceuticals #Pharmaceuticals
    newsbeep.com/us/641021/

  3. pub2cal AI/ML studies show a rapid increase.

    🤖 Only 7.6% FDA regulated.
    🔬 56.2% randomized, 58.9% prospective.
    🏥 44.2% hospital/clinic-sponsored.
    🌍 75.3% from high-income countries.

    #AI #ML #ClinicalTrials

    tnyp.me/a6XwRVdg/m

  4. AI/ML Trends in Clinical Trials (2010-2023)

    📈 Rapid increase in AI/ML studies post-2017, 62.8% from 2021-2023
    ⚕️ 56.2% randomized, 58.9% prospective designs in trials
    🏥 Major sponsors: hospitals/clinics (44.2%), academia (28%)
    🌍 Dominantly located in high-income countries (75.3%)
    📉 Low result reporting: only 5.6% available at study completion

    #AI #ML #ClinicalTrials #HIC #RCT #Healthcare #Pub2Post

    DOI: https://dev.tnyp.me/e6M2kG8b/m

  5. AI/ML Trends in Clinical Trials (2010-2023)

    📈 Rapid increase in AI/ML studies post-2017, 62.8% from 2021-2023
    ⚕️ 56.2% randomized, 58.9% prospective designs in trials
    🏥 Major sponsors: hospitals/clinics (44.2%), academia (28%)
    🌍 Dominantly located in high-income countries (75.3%)
    📉 Low result reporting: only 5.6% available at study completion

    #AI #ML #ClinicalTrials #HIC #RCT #Healthcare #Pub2Post

    DOI: https://dev.tnyp.me/e6M2kG8b/m

  6. AI/ML Trends in Clinical Trials (2010-2023)

    📈 Rapid increase in AI/ML studies post-2017, 62.8% from 2021-2023
    ⚕️ 56.2% randomized, 58.9% prospective designs in trials
    🏥 Major sponsors: hospitals/clinics (44.2%), academia (28%)
    🌍 Dominantly located in high-income countries (75.3%)
    📉 Low result reporting: only 5.6% available at study completion

    #AI #ML #ClinicalTrials #HIC #RCT #Healthcare #Pub2Post

    DOI: https://dev.tnyp.me/e6M2kG8b/m

  7. AI/ML Trends in Clinical Trials (2010-2023)

    📈 Rapid increase in AI/ML studies post-2017, 62.8% from 2021-2023
    ⚕️ 56.2% randomized, 58.9% prospective designs in trials
    🏥 Major sponsors: hospitals/clinics (44.2%), academia (28%)
    🌍 Dominantly located in high-income countries (75.3%)
    📉 Low result reporting: only 5.6% available at study completion

    #AI #ML #ClinicalTrials #HIC #RCT #Healthcare #Pub2Post

    DOI: https://dev.tnyp.me/e6M2kG8b/m

  8. AI/ML Trends in Clinical Trials (2010-2023)

    📈 Rapid increase in AI/ML studies post-2017, 62.8% from 2021-2023
    ⚕️ 56.2% randomized, 58.9% prospective designs in trials
    🏥 Major sponsors: hospitals/clinics (44.2%), academia (28%)
    🌍 Dominantly located in high-income countries (75.3%)
    📉 Low result reporting: only 5.6% available at study completion

    #AI #ML #ClinicalTrials #HIC #RCT #Healthcare #Pub2Post

    DOI: https://dev.tnyp.me/e6M2kG8b/m

  9. AI/ML studies show rapid growth in high-income countries 2010-2023.
    📈 3106 studies, with 7.6% FDA-regulated
    🏥 44.2% hospital-sponsored
    🧠 12.9% target neoplasms
    📊 Enrollment skewed, max 13,977,257
    #AI #ML #ClinicalTrials #Healthcare #Research #Pub2Post
    https://dev.tnyp.me/e6M2kG8b/m

  10. Most clinical trials don't fail because the science was wrong.
    They fail because:
    → Sites weren't activated on time
    → Enrollment targets were optimistic, not evidence-based
    → Data issues were caught late
    → No one owned the full picture
    That's a project management problem — not a scientific one.
    We wrote about how structured clinical project management prevents exactly this.

    #clinicalresearch #clinicaltrials #projectmanagement #CRO #pharma #drugdevelopment
    genelifecr.blogspot.com/2026/0

  11. In our latest article, we explore how Clinical Project Managementserves as the backbone of successful clinical trials — ensuring efficiency, quality, and compliance from study design to completion.
    If you're involved in clinical development, this provides a comprehensive view of how integrated project management drives better outcomes.
    #ClinicalResearch #CRO #ClinicalTrials #ProjectManagement #Pharma #DrugDevelopment #genelife

    genelifecr.blogspot.com/2026/0

  12. R/Medicine 2026 starts with 2 days of in-depth demos and workshops TOMORROW!

    There's still time to register!

    Full program here: rconsortium.github.io/RMedicin

  13. R/Medicine 2026 starts with 2 days of in-depth demos and workshops TOMORROW!

    There's still time to register!

    Full program here: rconsortium.github.io/RMedicin

    #rstats #clinicaltrials #healthdata #healthcare

  14. R/Medicine 2026 starts with 2 days of in-depth demos and workshops TOMORROW!

    There's still time to register!

    Full program here: rconsortium.github.io/RMedicin

    #rstats #clinicaltrials #healthdata #healthcare

  15. R/Medicine 2026 starts with 2 days of in-depth demos and workshops TOMORROW!

    There's still time to register!

    Full program here: rconsortium.github.io/RMedicin

    #rstats #clinicaltrials #healthdata #healthcare

  16. R/Medicine 2026 starts with 2 days of in-depth demos and workshops TOMORROW!

    There's still time to register!

    Full program here: rconsortium.github.io/RMedicin

    #rstats #clinicaltrials #healthdata #healthcare

  17. This coming week! R/Consortium 2026! May 5-8, 100% virtual

    Two days of in-depth, hands-on demos and workshops, then two days of Keynotes, Talks, Lightning Talks and plenty of time built in for your questions - Connect directly with speakers and peers

    Don't miss it!

    rconsortium.github.io/RMedicin

  18. UNLOCKING YOUTH? NEW AGE-REVERSING TREATMENTS SHOW GLIMMERS OF HOPE AMIDST GROWING CONCERNS

    A new drug designed to reverse cellular aging has entered human clinical trials. This marks a significant step from lab research to real-world testing for anti-aging treatments.

    #CellAging, #ClinicalTrials, #RegenerativeMedicine, #AntiAging, #Longevity

    newsletter.tf/drug-reverses-ce

  19. Thermo Fisher Navigates Mixed Q1 Amidst Clario Integration and Market Crosscurrents

    Thermo Fisher Scientific's Q1 2026 revenue hit $11.01 billion, beating estimates. The Clario acquisition closed early. See how it affects customers.

    #ThermoFisher, #Q1Earnings, #ClarioAcquisition, #Biotech, #ClinicalTrials

    newsletter.tf/thermo-fisher-q1

  20. Launch webinar
    Strengthening trust in #science through high-quality clinical #trials: Launch of WHO Good Practices for Clinical Trial Design and Implementation

    #ClinicalTrials #Research #Training #WHO #Medicine

    Date: May 4, 2026
    Time: 13:00-15:00 CEST

    Register here👇
    who.zoom.us/webinar/register/W

  21. Introduction to R for Clinical Data

    "A gentle introduction to R and data science for healthcare professionals and clinical researchers"

    Led by Richard Hanna, Data Science Supervisor with the Cell and Gene Therapy Informatics Team at the Children’s Hospital of Philadelphia

    At R/Medicine 2026, May 5-8! Register today!

    rconsortium.github.io/RMedicin

  22. R/Medicine 2026 is next week! Register now!

    Just one of the great lineup of workshops and demos:

    "You Should Probably Map That: Introduction to Geospatial Analysis in R"

    By Anjile An, Weill Cornell Medical College

    rconsortium.github.io/RMedicin

  23. Clinical trials alone don’t tell the full story.
    In today’s evolving healthcare landscape, companies need more than controlled data — they need real-world insights and market understanding.

    At Genelife Clinical Research, we integrate all three to help sponsors make smarter clinical and commercial decisions. #ClinicalResearch #CRO #RealWorldEvidence #RWE #Pharma #ClinicalTrials #MarketResearch #DrugDevelopment #HealthcareInsights #LifeSciences #genelife

    genelifecr.blogspot.com/2026/0

  24. R/Medicine 2026 covers R being used across the full health data workflow - from clinical data entry and REDCap pipelines to reproducible reporting, large-scale analysis, and AI-assisted tools.

    Register today! rconsortium.github.io/RMedicin

  25. R/Medicine 2026 covers R being used across the full health data workflow - from clinical data entry and REDCap pipelines to reproducible reporting, large-scale analysis, and AI-assisted tools.

    Register today! rconsortium.github.io/RMedicin

    #rstats #clinicaltrials #healthdata #datascience

  26. R/Medicine 2026 covers R being used across the full health data workflow - from clinical data entry and REDCap pipelines to reproducible reporting, large-scale analysis, and AI-assisted tools.

    Register today! rconsortium.github.io/RMedicin

    #rstats #clinicaltrials #healthdata #datascience

  27. R/Medicine 2026 covers R being used across the full health data workflow - from clinical data entry and REDCap pipelines to reproducible reporting, large-scale analysis, and AI-assisted tools.

    Register today! rconsortium.github.io/RMedicin

    #rstats #clinicaltrials #healthdata #datascience

  28. R/Medicine 2026 covers R being used across the full health data workflow - from clinical data entry and REDCap pipelines to reproducible reporting, large-scale analysis, and AI-assisted tools.

    Register today! rconsortium.github.io/RMedicin

    #rstats #clinicaltrials #healthdata #datascience

  29. R/Medicine 2026 is approaching, with keynotes on software sustainability, accountable algorithm design, and rigorous evaluation of generative AI.

    Join keynote talks from Yanina Bellini Saibene, David Robinson, and Peter Gruber.

    Register now: rconsortium.github.io/RMedicin

    @yabellini

  30. BioNTech reports promising Phase II data for uterine cancer ADC

    Trastuzumab pamirtecan, an investigational HER2‑targeted antibody-drug conjugate developed by BioNTech and DualityBio, has met the primary efficacy endpoint…
    #Europe #EU #ADC #BioNTech #Clinicaltrials #DualityBIO #endometrialcancer #European #oncology #uterinecancer
    europesays.com/europe/11565/

  31. Life Biosciences lands $80m to push cell reset therapy

    Fresh funding backs the first human trial of a therapy designed to make older, damaged cells act younger…
    #NewsBeep #News #Healthcare #CA #Canada #cellresettherapy #clinicaltrial #clinicaltrials #ER-100 #Health #LifeBiosciences
    newsbeep.com/ca/592932/